Given the complexity of lung cancer’s molecular biology, it may be of interest to analyze additional galectins, as well as other relevant lung cancer biomarkers such as ALK, TP53, and EGFR, simultaneously, to gain deeper insights into their implications in lung cancer. The gene discussed is TP53; the disease is lung carcinoma.